{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:27:02Z","timestamp":1781756822205,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T00:00:00Z","timestamp":1389916800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00345-014-1239-z","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T15:24:40Z","timestamp":1389885880000},"page":"1423-1432","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study"],"prefix":"10.1007","volume":"32","author":[{"given":"Nobutaka","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Minami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiji","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokumi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Nakamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,17]]},"reference":[{"key":"1239_CR1","unstructured":"National Comprehensive Cancer Network. http:\/\/www.nccn.com\/prostate_cancer.aspx . Accessed 31 Mar 2010"},{"key":"1239_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jjco\/hyr184","volume":"42","author":"T Matsuda","year":"2012","unstructured":"Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, Japan Cancer Surveillance Research Group (2012) Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol 42:139\u2013147","journal-title":"Jpn J Clin Oncol"},{"key":"1239_CR3","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1200\/JCO.2009.25.3245","volume":"28","author":"Y Pardo","year":"2010","unstructured":"Pardo Y, Guedea F, Aguil\u00f3 F, Fern\u00e1ndez P, Mac\u00edas V, Mari\u00f1o A, Herv\u00e1s A, Herruzo I, Ortiz MJ, Ponce de Le\u00f3n J, Craven-Bratle J, Su\u00e1rez JF, Boladeras A, Pont \u00c0, Ayala A, Sancho G, Mart\u00ednez E, Alonso J, Ferrer M (2010) Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol 28:4687\u20134696","journal-title":"J Clin Oncol"},{"key":"1239_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0302-2838(02)00019-2","volume":"41","author":"NN Stone","year":"2002","unstructured":"Stone NN, Stock RG (2002) Complication following permanent brachytherapy. Eur Urol 41:427\u2013433","journal-title":"Eur Urol"},{"key":"1239_CR5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0360-3016(01)02812-7","volume":"53","author":"J Bucci","year":"2002","unstructured":"Bucci J, Morris WJ, Keyes M, Spadinger I, Sidhu S, Moravan V (2002) Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 53:91\u201398","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1239_CR6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0090-4295(02)02142-8","volume":"61","author":"MA Elshaikh","year":"2003","unstructured":"Elshaikh MA, Angermeier K, Ulchaker JC, Klein EA, Chidel MA, Mahoney S, Wilkinson DA, Reddy CA, Ciezki JP (2003) Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy. Urology 61:152\u2013155","journal-title":"Urology"},{"key":"1239_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(99)00525-8","volume":"47","author":"GS Merrick","year":"2000","unstructured":"Merrick GS, Butler WM, Lief JH, Dorsey AT (2000) Temporal resolution of urinary morbidity following prostate brachytherapy. Int J Radiat Oncol Bio Phys 47:121\u2013128","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"1239_CR8","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0360-3016(01)02657-8","volume":"52","author":"J Locke","year":"2002","unstructured":"Locke J, Ellis W, Wallner K, Cavanagh W, Blasko J (2002) Risk factors for acute urinary retention requiring temporary intermittent catheterization after prostate brachytherapy: a prospective study. Int J Radiat Oncol Biol Phys 52:712\u2013719","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1239_CR9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.1996.14.2.449","volume":"14","author":"K Wallner","year":"1996","unstructured":"Wallner K, Roy J, Harrison L (1996) Tumor control and morbidity following transperineal iodine 125 implantation for stage T1\/T2 prostatic carcinoma. J Clin Oncol 14:449\u2013453","journal-title":"J Clin Oncol"},{"key":"1239_CR10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0022-5347(01)62542-4","volume":"160","author":"MD Terk","year":"1998","unstructured":"Terk MD, Stock RG, Stone NN (1998) Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate. J Urol 160:1379\u20131382","journal-title":"J Urol"},{"key":"1239_CR11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1999.17.2.517","volume":"17","author":"MJ Zelefsky","year":"1999","unstructured":"Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, Grann A, Gaudin P, Fuks Z, Leibel SA (1999) Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 17:517\u2013522","journal-title":"J Clin Oncol"},{"key":"1239_CR12","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0090-4295(02)01840-X","volume":"60","author":"GS Merrick","year":"2002","unstructured":"Merrick GS, Butler WM, Wallner KE, Lief JH, Galbreath RW (2002) Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology 60:650\u2013655","journal-title":"Urology"},{"key":"1239_CR13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1464-410X.2005.05346.x","volume":"95","author":"GS Merrick","year":"2005","unstructured":"Merrick GS, Butler WM, Wallner KE, Allen Z, Galbreath RW, Lief JH (2005) Brachytherapy related dysuria. BJU Int 95:597\u2013602","journal-title":"BJU Int"},{"key":"1239_CR14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2004.09.036","volume":"62","author":"MA Elshaikh","year":"2005","unstructured":"Elshaikh MA, Ulchaker JC, Reddy CA, Angermeier KW, Klein EA, Chehade N, Altman A, Ciezki JP (2005) Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study. Int J Radiat Oncol Biol Phys 62:164\u2013169","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1239_CR15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1442-2042.2011.02957.x","volume":"19","author":"M Yoshida","year":"2012","unstructured":"Yoshida M, Kudoh J, Homma Y, Kawabe K (2012) New clinical evidence of silodosin, an \u03b11A selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms. Int J Urol 19:306\u2013316","journal-title":"Int J Urol"},{"key":"1239_CR16","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1016\/j.ijrobp.2011.04.026","volume":"81","author":"H Tsumura","year":"2011","unstructured":"Tsumura H, Satoh T, Ishiyama H, Tabata K, Kotani S, Minamida S, Kimura M, Fujita T, Matsumoto K, Kitano M, Hayakawa K, Baba S (2011) Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial. Int J Radiant Oncol Biol Phys 81:e385\u2013e392","journal-title":"Int J Radiant Oncol Biol Phys"},{"key":"1239_CR17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0360-3016(02)02726-8","volume":"53","author":"R Choo","year":"2002","unstructured":"Choo R, Do V, Herschorn S, DeBoer G, Danjoux C, Morton G, Cheng CH, Barak I, Preiner J (2002) Urodynamic changes at 18\u00a0months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 53:290\u2013296","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"1239_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2011.10827.x","volume":"109","author":"P Grimm","year":"2012","unstructured":"Grimm P, Billiet l, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S (2012) Comparative analysis of prostate-specific antigen-free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(Suppl 1):22\u201329","journal-title":"BJU Int"},{"key":"1239_CR19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0360-3016(99)00069-3","volume":"44","author":"S Nag","year":"1999","unstructured":"Nag S, Beyer D, Friedland J, Grimm P, Nath R (1999) American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44:789\u2013799","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1239_CR20","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","volume":"21","author":"W Sch\u00e4fer","year":"2002","unstructured":"Sch\u00e4fer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, van Kerrebroeck P, International Continence Society (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261\u2013274","journal-title":"Neurourol Urodyn"},{"key":"1239_CR21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.juro.2006.10.018","volume":"177","author":"NN Stone","year":"2007","unstructured":"Stone NN, Stock RG (2007) The effect of brachytherapy, external beam irradiation and hormonal therapy on prostate volume. J Urol 177:925\u2013928","journal-title":"J Urol"},{"key":"1239_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2008.12.009","volume":"91","author":"SH Aaltomaa","year":"2009","unstructured":"Aaltomaa SH, Kataja VV, Lahtinen T, Palmgren JE, Forsell T (2009) Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy\u2013morbidity and outcome results. Radiother Oncol 91:213\u2013216","journal-title":"Radiother Oncol"},{"key":"1239_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2007.05.020","volume":"84","author":"D Ash","year":"2007","unstructured":"Ash D, Bottomley D, Al-Qaisieh B, Carey B, Gould K, Henry A (2007) A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localized prostate cancer. Radiother Oncol 84:135\u2013139","journal-title":"Radiother Oncol"},{"key":"1239_CR24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.coc.0000225412.24750.4c","volume":"29","author":"ED Crawford","year":"2006","unstructured":"Crawford ED, Kavanagh BD (2006) The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy. Am J Clin Oncol 29:517\u2013523","journal-title":"Am J Clin Oncol"},{"key":"1239_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1464-410X.2011.10800.x","volume":"110","author":"KM Snyder","year":"2012","unstructured":"Snyder KM, Stock RG, Buckstein M, Stone NN (2012) Long-term potency preservation following brachytherapy for prostate cancer. BJU Int 110:221\u2013225","journal-title":"BJU Int"},{"key":"1239_CR26","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.juro.2009.08.030","volume":"182","author":"Y Matsukawa","year":"2009","unstructured":"Matsukawa Y, Gotoh M, Komatsu T, Funahashi Y, Sassa N, Hattori R (2009) Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study. J Urol 182:2831\u20132835","journal-title":"J Urol"},{"key":"1239_CR27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijrobp.2005.01.040","volume":"62","author":"MS Anscher","year":"2005","unstructured":"Anscher MS, Chen L, Rabbani Z, Kang S, Larrier N, Huang H, Samulski TV, Dewhirst MW, Brizel DM, Folz RJ, Vujaskovic Z (2005) Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. Int J Radiat Oncol Biol Phys 62:255\u2013259","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1239_CR28","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1111\/j.1464-410X.2011.10814.x","volume":"110","author":"S Inoue","year":"2012","unstructured":"Inoue S, Saito M, Tsounapi P, Dimitriadis F, Ohmasa F, Kinoshita Y, Satoh K, Takenaka A (2012) Effect of silodosin on detrusor overactivity in the male spontaneously hypertensive rat. BJU Int 110:E118\u2013E124","journal-title":"BJU Int"},{"key":"1239_CR29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.urology.2009.05.045","volume":"75","author":"H Okutsu","year":"2010","unstructured":"Okutsu H, Matsumoto S, Hanai T, Noguchi Y, Fujiyasu N, Ohtake A, Suzuki M, Sato S, Sasamata M, Uemura H, Kurita T (2010) Effects of tamsulosin on bladder blood flow and bladder function in rats with bladder outlet obstruction. Urology 75:235\u2013240","journal-title":"Urology"},{"key":"1239_CR30","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.juro.2013.03.110","volume":"190","author":"Y Goi","year":"2013","unstructured":"Goi Y, Tomiyama Y, Nomiya M, Sagawa K, Aikawa K, Yamaguchi O (2013) Effects of silodosin, a selective \u03b11a-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction. J Urol 190:1116\u20131122","journal-title":"J Urol"},{"key":"1239_CR31","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1464-410X.2011.10623.x","volume":"109","author":"M Boettcher","year":"2012","unstructured":"Boettcher M, Haselhuhn A, Jakse G, Brehmer B, Kirschner-Hermanns R (2012) Overactive bladder syndrome: an underestimated long-term problem after treatment of patients with localized prostate cancer? BJU Int 109:1824\u20131830","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1239-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-014-1239-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-014-1239-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T17:31:13Z","timestamp":1565112673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-014-1239-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,17]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1007\/s00345-014-1239-z","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,17]]}}}